RFP Notice: Family Smoking Prevention and Tobacco Control Act National Longitudinal Study

Notice Number: NOT-DA-11-026

Key Dates
Release Date: March 24, 2011

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The National Institute on Drug Abuse (NIDA) plans on issuing a  solicitation  seeking qualified businesses with the capability conduct a large national longitudinal cohort study and establish a regulatory-science framework to monitor the behavioral and health impacts of provisions in the 2009 Family Smoking Prevention and Tobacco Control Act (FSPTCA).  A solicitation will be released through the Federal Business Opportunies website( URL: https://www.fbo.gov/ ).  The RFP will be released on or about April 5, 2011 and proposals will be due approximately 45 days thereafter.

Research Initiative Details

The FSPTCA gave the Food and Drug Administration (FDA) the authority to regulate tobacco-product advertising, labeling, marketing, constituents, ingredients and additives in the United States. These regulatory changes are expected to influence tobacco-product risk perceptions, use patterns, and exposures, and to reduce tobacco-related morbidity and mortality over time. The study initially will focus on designing the sample, establishing the cohort, collecting data on a yearly basis, developing a database, arranging a central specimen repository, and measuring and reporting on the near-term behavioral and health effects of the regulatory changes. NIDA anticipates that over time, the study will involve continued cohort monitoring, additional recruitment of young adults to the cohort at each wave, cross-sectional analyses within age groups and longitudinal data analysis, including analysis of distal outcomes, and small area estimation modeling. Results from this study are expected to inform the development, implementation, and evaluation of tobacco-product regulations in the United States (For detailed information on FSPTCA, see http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=111_cong_public_laws&docid=f:publ031.111.pdf).

Inquiries

Please direct all inquiries to:

Brian H. O’Laughlin
Contracting Officer
NIDA R&D Contracts Management Branch
Office of Acquisitions, NIDA
National Institutes of Health
6001 Executive Blvd., Room 4211 (MSC 9559)
Bethesda, MD  20892-9559
Phone: 301.443.6677
Fax: 301.443.7595
Email: olaughlinb@nida.nih.gov